---
title: "Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors"
date: 2025-08-27T19:47:23.541Z
source: "cnbc.com"
source_url: https://www.cnbc.com/2025/08/24/eli-lilly-oral-obesity-pill-novo-nordisk.html
---

## Shrnutí (CZ)
Eli Lilly's stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street.

---

[Otevřít zdroj](https://www.cnbc.com/2025/08/24/eli-lilly-oral-obesity-pill-novo-nordisk.html)
